+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Alzheimer's Disease Drugs Market Research Reports

From
Alzheimer's Disease Treatment Global Market Report 2024 - Product Thumbnail Image

Alzheimer's Disease Treatment Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Alzheimer's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Alzheimer's Disease Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
From
Alzheimer's Disease - Pipeline Insights, 2024 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Insights, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Alzheimer's Drugs - A Global Market Overview - Product Thumbnail Image

Alzheimer's Drugs - A Global Market Overview

  • Report
  • September 2024
  • 253 Pages
  • Global
From
From
From
From
Alzheimer's Drugs Global Market Report 2024 - Product Thumbnail Image

Alzheimer's Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Etanercept - Biosimilar Insight, 2024 - Product Thumbnail Image

Etanercept - Biosimilar Insight, 2024

  • Report
  • August 2024
  • 60 Pages
  • Global
From
Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Secretase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Secretase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Gamma Secretase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Gamma Secretase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Alzheimer's Disease Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs to treat Alzheimer's Disease. Alzheimer's Disease is a progressive neurological disorder that affects memory, thinking, and behavior. It is the most common form of dementia, and is estimated to affect over 5 million people in the United States alone. The Alzheimer's Disease Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include Eli Lilly, Pfizer, Novartis, Merck, and Johnson & Johnson. These companies are developing and marketing drugs to treat Alzheimer's Disease, such as cholinesterase inhibitors, memantine, and monoclonal antibodies. Additionally, many of these companies are researching and developing new treatments for Alzheimer's Disease, such as gene therapy and stem cell therapy. Show Less Read more